Cargando…

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study

PURPOSE: This open-label controlled study compared the therapeutic efficacy of three representative angiotensin II receptor blockers (ARBs) in hypertensive patients with type 2 diabetes attending a hospital outpatient clinic. The primary measure in this study was morning home blood pressure (BP). PA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daikuhara, Hiroyuki, Fukunaga, Kensaku, Ohshima, Tomie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933665/ https://www.ncbi.nlm.nih.gov/pubmed/24600204 http://dx.doi.org/10.2147/DDDT.S53253

Ejemplares similares

Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS
por: Jeong, Hyeon-Cheol, et al.
Publicado: (2021)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study
por: Nishida, Yayoi, et al.
Publicado: (2011)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
por: Niemeijer, Menco G., et al.
Publicado: (2009)

Management of Hypertension Using Olmesartan Alone or in Combination
por: Zhang, Xiaoshen, et al.
Publicado: (2017)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
por: Takami, Takeshi, et al.
Publicado: (2013)

Olmesartan: Induced maculopapular rash
por: Bhushan, Aruna, et al.
Publicado: (2013)

Enteropatía secundaria a olmesartán
por: Curieses Luengo, María, et al.
Publicado: (2017)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial [Corrigendum]
Publicado: (2013)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
por: Punzi, Henry A
Publicado: (2011)

Olmesartan/amlodipine: a review of its use in the management of hypertension
por: Kreutz, R
Publicado: (2011)

Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
por: Buendia, Richard, et al.
Publicado: (2017)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
por: Gao, Pingjin, et al.
Publicado: (2015)

Coto vedado /
por: Goytisolo, Juan
Publicado: (1986)

Coto Doñana
por: Díaz de los Reyes, A.
Publicado: (1979)

Coto vedado /
por: Goytisolo, Juan
Publicado: (1995)

Coto Bark
Publicado: (1879)

Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis
por: Roth, Eli M., et al.
Publicado: (2013)

Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments
por: Almutairy, Bjad K., et al.
Publicado: (2021)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)

Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016)

Olmesartan: A Little-Known Cause of Diarrhoea
por: Serôdio, Joana, et al.
Publicado: (2019)

Olmesartan medoxomil: Allergic reaction: case report
Publicado: (2022)

A Case Report of Olmesartan-Induced Enteropathy
por: Daines, Benjamin S, et al.
Publicado: (2021)

Olmesartan-Induced Enteropathy: A Case Report
por: Jadvani, Dharmikkumar, et al.
Publicado: (2023)

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation
por: Menne, Jan, et al.
Publicado: (2014)

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
por: Mandavdhare, Harshal Surendra, et al.
Publicado: (2017)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
por: Mason, R Preston
Publicado: (2011)

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
por: Ruilope, Luis M
Publicado: (2008)

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
por: Chrysant, S G, et al.
Publicado: (2010)

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
por: Omboni, Stefano, et al.
Publicado: (2018)

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
por: Sakata, Yasuhiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4057t1uc9f59ugv7iurgttcj3g